NO960325L - Tryptaseinhibitor - Google Patents

Tryptaseinhibitor

Info

Publication number
NO960325L
NO960325L NO960325A NO960325A NO960325L NO 960325 L NO960325 L NO 960325L NO 960325 A NO960325 A NO 960325A NO 960325 A NO960325 A NO 960325A NO 960325 L NO960325 L NO 960325L
Authority
NO
Norway
Prior art keywords
pct
novel
sec
date
vectors
Prior art date
Application number
NO960325A
Other languages
English (en)
Other versions
NO960325D0 (no
Inventor
Hans Fritz
Christian P Sommerhoff
Original Assignee
Ciba Geigy Ag
Ipc Gen Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag, Ipc Gen Pharma Ag filed Critical Ciba Geigy Ag
Publication of NO960325L publication Critical patent/NO960325L/no
Publication of NO960325D0 publication Critical patent/NO960325D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Luminescent Compositions (AREA)

Abstract

Nye Inhlbltorer av human tryptase, Isolering fra blodigler, nukleotldsekvenser kodende for nye inhlbltor molekyler eller fragmenter derav, vektorer Inneholdende de kodende sekvensene derav, vertsceller transformert med silke vektorer, rekombi- nant produksjon av Inhlbltorer, farmasøytiske sammensetninger Inneholdende nye Inhibltor molekyler og anvendelse l diagnostikk og terapi er beskrevet.
NO960325A 1993-07-26 1996-01-26 Tryptaseinhibitor NO960325D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93111930 1993-07-26
PCT/EP1994/002445 WO1995003333A2 (en) 1993-07-26 1994-07-25 Tryptase inhibitor

Publications (2)

Publication Number Publication Date
NO960325L true NO960325L (no) 1996-01-26
NO960325D0 NO960325D0 (no) 1996-01-26

Family

ID=8213112

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960325A NO960325D0 (no) 1993-07-26 1996-01-26 Tryptaseinhibitor

Country Status (13)

Country Link
US (1) US5972698A (no)
EP (1) EP0714408B1 (no)
JP (1) JPH09500532A (no)
AT (1) ATE245660T1 (no)
AU (1) AU694444B2 (no)
CA (1) CA2164221A1 (no)
DE (1) DE69432975T2 (no)
FI (1) FI960333A (no)
NO (1) NO960325D0 (no)
NZ (1) NZ271635A (no)
SG (1) SG52658A1 (no)
TW (1) TW492975B (no)
WO (1) WO1995003333A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0861085T3 (da) * 1995-11-13 2005-11-21 Vitaleech Bioscience N V Antivirale isolater opnået fra igler
AU1140797A (en) * 1995-12-15 1997-07-14 Novartis Ag Ldti crystals
GB9916913D0 (en) * 1999-07-19 1999-09-22 Natural Enviromental Research Inhibitor proteins
AU2005287557B2 (en) 2004-09-21 2011-10-13 Biontech Ag Use of microproteins as tryptase inhibitors
CN108017693A (zh) * 2017-12-14 2018-05-11 中国科学院昆明动物研究所 一种抗凝肽syap-1及其突变体和包括抗凝肽和/或突变体的抑制剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560584B2 (en) * 1983-07-28 1987-04-09 Bayer Aktiengesellschaft Homologues of aprotinin
US4666829A (en) * 1985-05-15 1987-05-19 University Of California Polypeptide marker for Alzheimer's disease and its use for diagnosis
JPS6351335A (ja) * 1986-08-20 1988-03-04 Fuji Oil Co Ltd 肥満細胞脱顆粒抑制剤
US5187153A (en) * 1986-11-17 1993-02-16 Scios Nova Inc. Methods of treatment using Alzheimer's amyloid polypeptide derivatives
US4912206A (en) * 1987-02-26 1990-03-27 The United States Of America As Represented By The Department Of Health And Human Services CDNA clone encoding brain amyloid of alzheimer's disease
JPH01110697A (ja) * 1987-07-03 1989-04-27 Taisho Pharmaceut Co Ltd 新規プロテアーゼ阻害物質
ATE103930T1 (de) * 1988-03-07 1994-04-15 Ciba Geigy Ag Modifizierte proteine.
NZ231658A (en) * 1988-12-12 1992-05-26 Fmc Corp Inhibitors of protoporphyrinogen oxidase and compositions for killing tumour cells
CA2025537A1 (en) * 1989-02-22 1990-08-23 Yoshimasa Ike Protease inhibitor and process for producing it
IL98405A0 (en) * 1990-06-11 1992-07-15 Fmc Corp Pharmaceutical compositions containing enzyme inhibiting agents

Also Published As

Publication number Publication date
EP0714408A1 (en) 1996-06-05
WO1995003333A2 (en) 1995-02-02
NO960325D0 (no) 1996-01-26
SG52658A1 (en) 1998-09-28
EP0714408B1 (en) 2003-07-23
JPH09500532A (ja) 1997-01-21
FI960333A0 (fi) 1996-01-24
TW492975B (en) 2002-07-01
AU7532494A (en) 1995-02-20
US5972698A (en) 1999-10-26
DE69432975T2 (de) 2004-05-06
AU694444B2 (en) 1998-07-23
DE69432975D1 (en) 2003-08-28
WO1995003333A3 (en) 1995-03-23
ATE245660T1 (de) 2003-08-15
CA2164221A1 (en) 1995-02-02
NZ271635A (en) 1998-04-27
FI960333A (fi) 1996-01-24

Similar Documents

Publication Publication Date Title
BR9406689A (pt) Adenovirus recombinante defectivo utilização deste adenovirus e composição farmacêutica obtida
HK1001973A1 (en) Sulfonamides
NO20006717L (no) Proteaseinhibitorer
ZA963593B (en) IL-6 activity inhibitor
DK0910647T3 (da) Human DNase i hyperaktive varianter
TW279166B (no)
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
NO962388L (no) Polyolblandinger og deres anvendelse ved fremstilling av höyelastiske polyuretanskum
FI960333A (fi) Tryptaasi-inhibiittori
ATE332379T1 (de) Menschliche dnase resistent gegen actininhibitoren
GB9309509D0 (en) Thrombin inhibitors
NO961357D0 (no) Nye terapeutisk aktive peptidforbindelser i blodkoagulasjonskaskaden, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
DE69529235D1 (de) Menschliche dnase i varianten
FI962047A0 (fi) Endoteliiniä muuntava entsyymi
WO2002096938A3 (en) Human kunitz-type protease inhibitor

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application